Patients with type 1 and 2 diabetes mellitus ( DM ) referred for coronary artery bypass grafting ( CABG ) were randomized to receive GIK solution ( GIK -- study group ) in the first 24 hours intraoperatively or to receive official Clinical protocol without GIK solution ( non GIK - control group ) .